COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean

Virtual Health Sciences Library

  • Home
  • Search
  • Knowledge Base
  • Get a journal indexed in the Index Medicus
  • MyVHSL
  1. Home
  2. IMEMR
  3. Search Result
  4. Usefulness of genome-wide association studies to identify novel genetic variants underlying the plasma lipoprotein metabolism as risk factors for CAD

Usefulness of genome-wide association studies to identify novel genetic variants underlying the plasma lipoprotein metabolism as risk factors for CAD

Authors

Almontashiri Naif A. M.
Hannan, Mohammed
Taibah University ; University of Ottawa Heart Institute, Center for Genetics and Inherited Diseases ; Harvard Medical School, Department of Biochemistry, Microbiology and Immunology ;

J. Taibah Univ. Med. Sci. 2015; 10 (3): 266-270
Journal of Taibah University Medical Sciences
Journal Country: Saudi Arabia
P-ISSN: 1658-3612
Type of Publication: Review
Category: Humans,
Type of Research: Clinical
Keywords: Coronary Artery Disease / Genetics
Broad Subjects: Noncommunicable Diseases, Genome-Wide Association Study ,Lipoproteins ,Metabolism ,Risk Factors ,Cholesterol ,Blood ,Atherosclerosis ,Polymorphism, Single Nucleotide
Citation: Naif A. M. Almontashiri ,Mohammed Hannan , Usefulness of genome-wide association studies to identify novel genetic variants underlying the plasma lipoprotein metabolism as risk factors for CAD, J. Taibah Univ. Med. Sci. 2015; 10 (3): 266-270

Abstract English

Coronary artery disease [CAD] is a major killer across the world. The pathogenesis of CAD is a construct of multiple predisposing elements, including environmental, health and genetic factors. Traditional risk factors for CAD include age, hypertension, diabetes, smoking, and dyslipidaemia. Optimizing the lipid levels to within the normal range significantly and drastically reduces the risk of coronary atherosclerosis. Genome-wide association studies [GWASs] promise to accurately identifying the variants that increase or decrease the risks of multiple and complex disorders. In this review, we shed light on and discuss the recent GWASs of lipoprotein genetics and how such studies have provided new pathways and pharmacological targets that might enable the control the pathological plasma cholesterol levels

Full Text English

Subscribe to VHSL Newsletters

© 2020 WHO – EMRO